Y Intercept Hong Kong Ltd Acquires Shares of 13,984 CME Group Inc. $CME

Y Intercept Hong Kong Ltd acquired a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 13,984 shares of the financial services provider’s stock, valued at approximately $3,854,000.

Several other institutional investors have also added to or reduced their stakes in CME. Catalyst Capital Advisors LLC raised its holdings in CME Group by 256.9% during the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock valued at $971,000 after acquiring an additional 2,636 shares during the period. OMNI 360 Wealth Inc. bought a new stake in CME Group during the 1st quarter valued at $367,000. Fulcrum Equity Management bought a new stake in CME Group during the 1st quarter valued at $258,000. AIA Group Ltd raised its holdings in CME Group by 17.8% during the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock valued at $4,416,000 after acquiring an additional 2,510 shares during the period. Finally, Summit Trail Advisors LLC raised its holdings in CME Group by 28.8% during the 1st quarter. Summit Trail Advisors LLC now owns 5,323 shares of the financial services provider’s stock valued at $1,412,000 after acquiring an additional 1,189 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at CME Group

In other CME Group news, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the transaction, the general counsel directly owned 7,851 shares in the company, valued at $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider owned 17,440 shares in the company, valued at $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 13,043 shares of company stock valued at $3,527,956 over the last ninety days. Insiders own 0.30% of the company’s stock.

CME Group Stock Down 1.8%

CME stock opened at $266.33 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company’s 50 day moving average is $266.38 and its 200 day moving average is $272.08. The stock has a market cap of $95.98 billion, a price-to-earnings ratio of 25.81, a price-to-earnings-growth ratio of 4.58 and a beta of 0.41. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.05. The company had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. CME Group’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the prior year, the business earned $2.68 earnings per share. Sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

Analyst Ratings Changes

CME has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft raised shares of CME Group from a “hold” rating to a “buy” rating and boosted their target price for the company from $266.00 to $300.00 in a report on Thursday, October 23rd. Barclays lowered their price target on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 8th. Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and increased their price target for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. The Goldman Sachs Group increased their price target on shares of CME Group from $262.00 to $263.00 and gave the stock a “sell” rating in a report on Thursday, October 23rd. Finally, Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Eight research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $284.53.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.